HUM vs MOH: fair value comparison
Humana Inc. and Molina Healthcare, Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, HUM currently sits closer to the top of our discount ranking. HUM carries the stronger quality grade.
| HUM | MOH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $385.54 | $200.00 |
| 12-month range | $176.95–$374.50 | $135.82–$195.62 |
| Sector rank | #108 of 113 Healthcare | #112 of 113 Healthcare |
| Quality grade | C | F |
| Leverage | Moderate | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| DCF cross-check | Fairly Valued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: HUM fair value analysis · MOH fair value analysis